Two Different Regimens of Misoprostol in Retained Placenta

• Status: Completed
• Trial end date: 2019-02-14
• Target enrollment: 0
• Participant gender: Female

Summary

This study evaluates intra umbilical vein injection of 800 µg versus 400 µg misoprostol for the treatment of retained placenta to reduce the need of manual removal of placenta under general anaesthesia

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hawler Medical University
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

• women with a singleton pregnancy, delivered vaginally

• 28 weeks of gestation and more,

• had a prolonged third stage of labor (more than 30 minutes) despite active management,

• Haemodynamically stable and accept to participate in the trial

Exclusion Criteria:

• multiple pregnancies,

• previous caesarean delivery,

• haemodynamically instability, severe anaemia (haemoglobin concentration <8 g/dL),

• chorioamnionitis

• Refused to participate in the trial